PT  - JOURNAL ARTICLE
AU  - Tariq, Amna
AU  - Undurraga, Eduardo A.
AU  - Laborde, Carla Castillo
AU  - Vogt-Geisse, Katia
AU  - Luo, Ruiyan
AU  - Rothenberg, Richard
AU  - Chowell, Gerardo
TI  - Transmission dynamics and control of COVID-19 in Chile, March-October, 2020
AID  - 10.1101/2020.05.15.20103069
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.15.20103069
4099  - http://medrxiv.org/content/early/2020/12/15/2020.05.15.20103069.short
4100  - http://medrxiv.org/content/early/2020/12/15/2020.05.15.20103069.full
AB  - Since the detection of the first case of COVID-19 in Chile on March 3rd, 2020, a total of 513188 cases, including ∼14302 deaths have been reported in Chile as of November 2nd, 2020. Here, we estimate the reproduction number throughout the epidemic in Chile and study the effectiveness of control interventions especially the effectiveness of lockdowns by conducting short-term forecasts based on the early transmission dynamics of COVID-19. Chile’s incidence curve displays early sub-exponential growth dynamics with the deceleration of growth parameter, p, estimated at 0.8 (95% CI: 0.7, 0.8) and the reproduction number, R, estimated at 1.8 (95% CI: 1.6, 1.9). Our findings indicate that the control measures at the start of the epidemic significantly slowed down the spread of the virus. However, the relaxation of restrictions and spread of the virus in low-income neighborhoods in May led to a new surge of infections, followed by the reimposition of lockdowns in Greater Santiago and other municipalities. These measures have decelerated the virus spread with R estimated at ∼0.96(95% CI: 0.95, 0.98) as of November 2nd, 2020. The early sub-exponential growth trend (p ∼0.8) of the COVID-19 epidemic transformed into a linear growth trend (p ∼0.5) as of July 7th, 2020, after the reimposition of lockdowns. While the broad scale social distancing interventions have slowed the virus spread, the number of new COVID-19 cases continue to accrue, underscoring the need for persistent social distancing and active case detection and isolation efforts to maintain the epidemic under control.Author summary In context of the ongoing COVID-19 pandemic, Chile has been one of the hardest-hit countries in Latin America, struggling to contain the spread of the virus. In this manuscript, we employ renewal equation to estimate the reproduction number (R) for the early ascending phase of the COVID-19 epidemic and by July 7th, 2020 to guide the magnitude and intensity of interventions required to combat the COVID-19 epidemic. We also estimate the instantaneous reproduction number throughout the epidemic in Chile. Moreover, we generate short-term forecasts based on the epidemic trajectory using phenomenological models, and assess counterfactual scenarios to understand any additional resources required to contain the virus’ spread. Our results indicate early sustained transmission of SARS-CoV-2. However, the initial control measures at the start of the epidemic significantly slowed down the spread of the virus. The easing of COVID-19 restrictions in April led to a new wave of infections, followed by the re-imposition of lockdowns in Greater Santiago and other municipalities. Most recent estimates of reproduction number indicate a decline in the virus transmission. While broad-scale social distancing interventions have slowed the virus spread, the number of new COVID-19 cases continue to accrue, underscoring the need for persistent social distancing efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementG.C. is partially supported from NSF grants 1610429 and 1633381 and R01 GM 130900Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The manuscript utilizes secondary data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available.